Gene · 79813
EHMT1: euchromatic histone lysine methyltransferase 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EHMT1: euchromatic histone lysine methyltransferase 1. Genes, record 79813. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/79813
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9H9B1 | Histone-lysine N-methyltransferase EHMT1 | 1,298 | 23 | Ensembl, GeneID, HGNC |
Source UniProt
Patents21
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45352 | Q9H9B1 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 16517 | Q9H9B1 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 4637 | Q9H9B1 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6244 | Q9H9B1 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6244 | Q9H9B1 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 16517 | Q9H9B1 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 4637 | Q9H9B1 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 4637 | Q9H9B1 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 4644 | Q9H9B1 | Espacenet |
| US 11920164 B2 | 2024-03-05 | 200 | Q9H9B1 | Espacenet |
1 to 10 of 21
See all 21 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,962
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EHMT1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 20 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30DK026687 | New York Obesity Research Center | 6 | 2025 |
| R01DA007359 | Molecular Studies of Cocaine Action in Brain | 6 | 2025 |
| R01DK097441 | Molecular mechanisms of UCP1-independent pathways in metabolic health | 6 | 2025 |
| P01CA125066 | Discovery of Anticancer Agents of Diverse Natural Origin | 5 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 5 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 5 | 2025 |
1 to 10 of 1,962Source NIH's project files
See all 1,962 nih grantsPapers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deep phenotyping of EHMT1 ankyrin repeat domain missense variants in Kleefstra syndrome by multi-tiered structural genomics analyses at atomic resolution. | Hum Mol Genet | 2026 | 42804670 | PubTator, text mining | PubMed |
| TDP-43 dysfunction induces cryptic circular RNAs in ALS/FTD. | bioRxiv | 2026 | 42779765 | PubTator, text mining | PubMed |
| Adjuvant Glucagon-Like Peptide-1 Receptor Agonist Therapy Post-Bariatric Surgery: An Exploratory Single-Institution Analysis. | J Surg Res | 2026 | 42767161 | PubTator, text mining | PubMed |
| Low-dose polysaccharides exert dual redox effects via the ROS-mediated MAPK pathway: Antioxidant alone or pro-oxidant when GLP is combined with doxorubicin in A2780 ovarian cancer cells. | Cell Signal | 2026 | 42759906 | PubTator, text mining | PubMed |
| Association of GLP-1-based therapy with asthma-related outcomes in patients with obesity: a propensity-matched retrospective cohort study. | Expert Rev Respir Med | 2026 | 42733229 | PubTator, text mining | PubMed |
| Combined loss of histone methyltransferases GLP and G9a disrupts neural crest cell fate determination. | J Clin Invest | 2026 | 42593859 | PubTator, text mining | PubMed |
| Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6-Month Claims Database Analysis. | Diabetes Obes Metab | 2026 | 42575714 | PubTator, text mining | PubMed |
| Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation. | Obes Pillars | 2026 | 42529748 | PubTator, text mining | PubMed |
| A role for EHMT2 in a novel autosomal recessive neurodevelopmental syndrome? A case report. | Front Genet | 2026 | 42434347 | PubTator, text mining | PubMed |
| Epigenomic dysregulation in the bone marrow mesenchymal stem cells of acquired aplastic anemia patients: An in silico and in vitro study. | Mol Biol Rep | 2026 | 42429854 | PubTator, text mining | PubMed |
1 to 10 of 2,587
See all 2,587 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/79813
GET https://conductscience.org/api/genes/v1/79813/patents?page=2